IGF2BP1 and osteosarcoma: More importantly, both overall and disease-free survivals of osteosarcoma patients with miR-150-low/IGF2BP1-high were shortest, compared to miR-150-low/IGF2BP1-low, miR-150-high/IGF2BP1-high, miR-150-high/IGF2BP1-low groups (Fig. 2e, f, respectively; both P < 0.001).